|
Preface |
6 |
|
|
Contents |
8 |
|
|
Contributors |
10 |
|
|
Chapter 1: Normal Sleep |
14 |
|
|
Normal Sleep Stages and Architecture |
14 |
|
|
Breathing During Sleep: Ventilation and the Upper Airway |
17 |
|
|
Summary of Normal Breathing and Ventilation During Sleep |
17 |
|
|
Effect of Sleep on Control of Breathing |
18 |
|
|
Effect of Sleep on Upper-Airway Structure and Function |
18 |
|
|
Cardiovascular Function During Sleep |
22 |
|
|
Endocrine Function During Sleep |
23 |
|
|
Gastrointestinal Function During Sleep |
23 |
|
|
Summary of Keypoints |
24 |
|
|
References |
25 |
|
|
Chapter 2: Pharmacology of Sleep |
29 |
|
|
Introduction |
29 |
|
|
Sleep-Promoting Drugs |
30 |
|
|
Benzodiazepines |
30 |
|
|
Nonbenzodiazepine Receptor Agonists (NBRA) |
32 |
|
|
Barbiturates Derivatives |
39 |
|
|
Melatonin Receptor Agonists |
39 |
|
|
Ramelteon |
39 |
|
|
Tasimelteon |
40 |
|
|
Melatonin |
43 |
|
|
Antidepressants and Antipsychotics |
43 |
|
|
Trazodone |
43 |
|
|
Tricyclic Antidepressants (TCA) |
44 |
|
|
SSRI and SNRI |
44 |
|
|
Other Antidepressants |
47 |
|
|
Antipsychotic Agents |
47 |
|
|
Other Sedating Drugs |
47 |
|
|
Newer Sedatives Under Development |
48 |
|
|
Almorexant |
48 |
|
|
Agomelatine |
48 |
|
|
Stimulants/Wake-Promoting Drugs |
49 |
|
|
Amphetamine-Like Substances |
49 |
|
|
Modafinil |
49 |
|
|
Armodafinil |
53 |
|
|
Sodium Oxybate |
54 |
|
|
Drugs of Abuse |
55 |
|
|
New Drugs Under Development |
57 |
|
|
Summary of Keypoints |
57 |
|
|
References |
58 |
|
|
Chapter 3: Obstructive Sleep Apnea: Diagnosis with Polysomnography and Portable Monitors |
67 |
|
|
Introduction |
67 |
|
|
Prevalence and Epidemiology |
68 |
|
|
Risk Factor |
68 |
|
|
Clinical History |
69 |
|
|
Physical Exam |
72 |
|
|
Diagnosis of OSA |
72 |
|
|
Overnight Polysomnography (PSG) |
72 |
|
|
Split Night Study (Diagnosis Combined with Titration) |
75 |
|
|
Portable Monitoring (PM) |
76 |
|
|
Types of PMs (Type II–IV) |
76 |
|
|
When Should PM Be Considered for Diagnosis of OSA? |
77 |
|
|
Current Roles of Autotitrating Positive Airway Pressure (APAP) |
78 |
|
|
Cost Effectiveness of PSG vs. PM |
79 |
|
|
Utilities of Multiple Sleep Latency Test (MSLT) in OSA |
79 |
|
|
Future Outlook |
80 |
|
|
Summary Outline |
80 |
|
|
References |
81 |
|
|
Chapter 4: Approach to Hypersomnia |
85 |
|
|
Introduction |
85 |
|
|
Determinants of Daytime Sleepiness |
86 |
|
|
Sleep Factors |
86 |
|
|
Quantity of Sleep |
86 |
|
|
Quality of Sleep |
86 |
|
|
Circadian Rhythm |
87 |
|
|
Medications |
87 |
|
|
Demographic Factors |
88 |
|
|
Age |
88 |
|
|
Gender |
88 |
|
|
Race |
88 |
|
|
Obesity |
88 |
|
|
Pathology of the Central Nervous System |
89 |
|
|
Measurement of Daytime Sleepiness |
89 |
|
|
Multiple Sleep Latency Test (MSLT) |
89 |
|
|
Maintenance of Wakefulness Test (MWT) |
90 |
|
|
Epworth Sleepiness Scale (ESS) |
91 |
|
|
Summary of Measurements of Excessive Daytime Sleepiness |
93 |
|
|
Differential Diagnosis |
93 |
|
|
Approach to the Sleepy Patient |
95 |
|
|
Summary of Keypoints |
97 |
|
|
References |
97 |
|
|
Chapter 5: Obstructive Sleep Apnea: Epidemiology of Sleep Apnea |
102 |
|
|
Introduction |
102 |
|
|
Clinical Definitions of Obstructive Sleep Apnea |
103 |
|
|
Prevalence |
106 |
|
|
North America |
109 |
|
|
Europe |
109 |
|
|
Asia |
110 |
|
|
South America |
110 |
|
|
Australasia |
111 |
|
|
Disease Progression |
111 |
|
|
Risk Factors |
112 |
|
|
Obesity |
112 |
|
|
Age |
114 |
|
|
Gender, Menopause, and Pregnancy |
114 |
|
|
Craniofacial Features |
115 |
|
|
Ethnicity |
116 |
|
|
Alcohol and Cigarette Consumption |
117 |
|
|
Familial/Genetic Factors |
118 |
|
|
Summary of Keypoints |
118 |
|
|
References |
119 |
|
|
Chapter 6: Obstructive Sleep Apnea: Clinical Features and Adverse Consequences |
125 |
|
|
Introduction |
125 |
|
|
Risk Factors for OSA |
127 |
|
|
Obesity |
127 |
|
|
Age |
128 |
|
|
Sex |
128 |
|
|
Ethnicity |
128 |
|
|
Bony Structures |
129 |
|
|
Diseases Associated with Edematous States |
129 |
|
|
Positive Family History |
129 |
|
|
Hypothyroidism |
130 |
|
|
Presence of Co-Morbid Conditions |
130 |
|
|
Clinical Symptoms |
130 |
|
|
Physical Signs |
131 |
|
|
Adverse Consequences of OSA |
133 |
|
|
Consequences Directly Linked to Symptoms |
133 |
|
|
Cardiovascular and Metabolic Consequences |
133 |
|
|
Hypertension |
134 |
|
|
Coronary Artery Disease |
135 |
|
|
Stroke |
135 |
|
|
Arrhythmias |
136 |
|
|
Diabetes and Metabolic Syndrome |
136 |
|
|
Conclusion |
137 |
|
|
Summary of Keypoints |
137 |
|
|
Chapter 7: Assessments of Driving Risk in Sleep Apnea |
139 |
|
|
Scope of the Problem |
139 |
|
|
Factors in Driving Risk |
141 |
|
|
The Interactive Responsibilities of a Driving Assessment |
143 |
|
|
Potential for Liability Risk for Pulmonary Physicians |
144 |
|
|
Societal Implications |
146 |
|
|
Lessons from the Alcohol Literature |
146 |
|
|
Principles in Assessment of Risk by the Pulmonary Physician |
149 |
|
|
Summary of Keypoints |
150 |
|
|
References |
150 |
|
|
Chapter 8: Nasal Continuous Positive Airway Pressure (CPAP) Treatment |
153 |
|
|
Mechanisms |
153 |
|
|
Beneficial Effects |
154 |
|
|
Excessive Daytime Sleepiness |
154 |
|
|
Blood Pressure |
154 |
|
|
Pulmonary Hypertension |
155 |
|
|
Heart Failure |
155 |
|
|
Cardiac Arrhythmias |
155 |
|
|
Neurocognitive Function |
156 |
|
|
Glucose Metabolism |
156 |
|
|
Motor Vehicle Accidents |
157 |
|
|
Adverse Effects |
157 |
|
|
Setting Up CPAP |
157 |
|
|
Titration |
158 |
|
|
Auto Titration |
158 |
|
|
Predictive Equations and Bedpartner Titration |
159 |
|
|
CPAP Modifications |
159 |
|
|
Adherence |
160 |
|
|
Conclusion |
160 |
|
|
Summary of Keypoints |
161 |
|
|
References |
161 |
|
|
Chapter 9: Obstructive Sleep Apnea: Oral Appliances |
164 |
|
|
Introduction |
164 |
|
|
Types of Appliances |
165 |
|
|
Mechanism of Action |
166 |
|
|
Efficacy and Effectiveness in the Treatment of OSA |
167 |
|
|
Impact on Polysomnographic Outcomes |
167 |
|
|
Impact on Health Outcomes |
168 |
|
|
Long-Term Efficacy |
169 |
|
|
Effectiveness Compared with Other Treatments |
169 |
|
|
Patient Selection and Prediction of Treatment Outcome |
171 |
|
|
Indications for Treatment |
171 |
|
|
Oral Considerations |
171 |
|
|
Indicators of Treatment Success |
171 |
|
|
Techniques for Predicting Outcome |
172 |
|
|
Contraindications |
175 |
|
|
Appliance Titration Protocols |
175 |
|
|
Adverse Effects |
176 |
|
|
Treatment Adherence |
177 |
|
|
Interdisciplinary Care Model |
178 |
|
|
Future Research |
178 |
|
|
Conclusion |
179 |
|
|
Summary of Keypoints |
179 |
|
|
References |
180 |
|
|
Chapter 10: Obstructive Sleep Apnea: Surgery |
184 |
|
|
Introduction |
184 |
|
|
Clinical Evaluation |
185 |
|
|
Background and Clinical Context of Surgical Therapy |
185 |
|
|
Role of Surgical Therapy |
186 |
|
|
Patient Evaluation |
187 |
|
|
Snoring |
188 |
|
|
Nasal Surgery |
189 |
|
|
Anatomy and Physiology |
189 |
|
|
Allergic Rhinitis and Sleep |
190 |
|
|
Pathophysiology of Nasal Obstruction and Sleep Disturbance |
192 |
|
|
Nasal Obstruction and Sleep-Disordered Breathing |
193 |
|
|
Surgical Treatment of Nasal Obstruction |
193 |
|
|
Nasal Surgery and Improved Effectiveness of Medical Therapy for OSA |
194 |
|
|
Oropharyngeal Surgery |
195 |
|
|
History |
195 |
|
|
A Paradigm Shift |
196 |
|
|
The Importance of Uvular Preservation |
197 |
|
|
Palatal Anatomy and Examination |
197 |
|
|
Surgical Techniques |
199 |
|
|
Expansion Sphincter Pharyngoplasty |
199 |
|
|
Transpalatal Advancement |
200 |
|
|
Hypopharyngeal Surgery |
201 |
|
|
Background |
201 |
|
|
Anatomy |
202 |
|
|
Hypopharyngeal Surgical Techniques |
204 |
|
|
Maxillomandibular Advancement Surgery |
205 |
|
|
Conclusion |
206 |
|
|
Summary of Keypoints |
206 |
|
|
References |
207 |
|
|
Chapter 11: Sleep and Lung Disease |
211 |
|
|
Introduction |
211 |
|
|
Sleep and COPD |
211 |
|
|
Hypoventilation |
212 |
|
|
Measurement of Hypoventilation and Respiratory Dysfunction |
213 |
|
|
Clinical Consequences of Sleep Hypoxemia in COPD |
213 |
|
|
Diagnosis of Nocturnal Hypoxemia in COPD |
214 |
|
|
Treatment of Nocturnal Hypoxemia |
214 |
|
|
Medications |
215 |
|
|
Noninvasive Positive Pressure Ventilation |
216 |
|
|
COPD and Obstructive Sleep Apnea: The Overlap Syndrome |
216 |
|
|
Sleep and Asthma |
216 |
|
|
Sleep Disturbances in Nocturnal Asthma |
217 |
|
|
Diagnosis |
217 |
|
|
Sleep and Restrictive Lung Disorders |
217 |
|
|
Chest Wall Disorders |
218 |
|
|
Pathophysiology of Hypoxemia |
218 |
|
|
Diagnosis |
219 |
|
|
Therapy |
219 |
|
|
Interstitial Lung Disease |
219 |
|
|
Diagnosis |
219 |
|
|
Treatment |
220 |
|
|
Sleep and Obesity: Hypoventilation Disorders |
220 |
|
|
Pathogenesis |
220 |
|
|
Clinical Features |
221 |
|
|
Diagnosis |
221 |
|
|
Therapy |
221 |
|
|
Weight Loss |
222 |
|
|
Summary of Keypoints |
222 |
|
|
References |
223 |
|
|
Chapter 12: Central Sleep Apnea |
226 |
|
|
Determinants of Central Apnea During NREM Sleep |
226 |
|
|
Hypocapnia |
226 |
|
|
Short-Term Potentiation |
227 |
|
|
Duration of Hyperpnea |
227 |
|
|
Role of Upper Airway Reflexes |
227 |
|
|
Mechanisms Perpetuating Breathing Instability |
228 |
|
|
Pathophysiologic Classification of Central Sleep Apnea |
228 |
|
|
Central Sleep Apnea Secondary to Hypoventilation |
229 |
|
|
Central Apnea Secondary to Hyperventilation |
230 |
|
|
Central Apnea Risk Factors |
230 |
|
|
Sleep State |
230 |
|
|
Age and Gender |
231 |
|
|
Medical Conditions |
231 |
|
|
Clinical Features and Diagnosis |
232 |
|
|
Management |
233 |
|
|
Positive Pressure Therapy |
233 |
|
|
Pharmacological Therapy |
234 |
|
|
Supplemental O 2 and CO 2 |
235 |
|
|
Approach in Selected Clinical Syndromes |
235 |
|
|
Summary |
235 |
|
|
Summary of Keypoints |
236 |
|
|
References |
236 |
|
|
Chapter 13: Insomnia: Etiology, Clinical Manifestations, and Morbidity |
240 |
|
|
Introduction |
240 |
|
|
DSM – IV |
243 |
|
|
ICSD – II |
243 |
|
|
Prevalence and Risk Factors of Insomnia |
245 |
|
|
Pathophysiology of Insomnia |
246 |
|
|
Clinical Assessment |
248 |
|
|
Sleep History |
248 |
|
|
Medical History |
249 |
|
|
Psychiatric History |
249 |
|
|
Family History |
249 |
|
|
Medication History |
249 |
|
|
Functional Outcomes Associated with Insomnia |
251 |
|
|
Conclusion |
251 |
|
|
Summary of Keypoints |
252 |
|
|
References |
252 |
|
|
Chapter 14: Management of Insomnia |
256 |
|
|
Introduction |
256 |
|
|
Control of Breathing During Sleep |
258 |
|
|
Pulmonary Disorders and Sleep |
260 |
|
|
Bronchospastic Airway Disorders |
260 |
|
|
Interstitial Lung Diseases and Sleep |
260 |
|
|
Kyphoscoliosis, Restrictive Thoracic Cage Disorders, and Sleep |
262 |
|
|
High Altitude Sickness and Insomnia |
264 |
|
|
Carbonic Anhydrase Inhibitors: Acetazolamide |
265 |
|
|
Benzodiazepines |
265 |
|
|
Non-benzodiazepine Benzodiazepine Receptor Agonists |
266 |
|
|
Oral Steroids |
267 |
|
|
Other Medication Used to Treat Insomnia at High Altitude |
267 |
|
|
Medications Used to Treat Insomnia |
267 |
|
|
Efficacy of Hypnotics |
268 |
|
|
Safety of Medications Commonly Used in Insomnia |
272 |
|
|
Sedating Antidepressants |
275 |
|
|
Cognitive-Behavioral Therapy of Insomnia |
276 |
|
|
Other Medications |
276 |
|
|
Summary of Keypoints |
277 |
|
|
References |
278 |
|
|
Chapter 15: Circadian Disorders |
284 |
|
|
Circadian Biology |
284 |
|
|
Circadian Rhythm Sleep Disorders |
286 |
|
|
Delayed Sleep Phase Disorder |
286 |
|
|
Diagnosis of Delayed Sleep Phase Disorder |
287 |
|
|
Treatment of Delayed Sleep Phase Disorder |
287 |
|
|
Advanced Sleep Phase Disorder |
289 |
|
|
Diagnosis of Advanced Sleep Phase Disorder |
289 |
|
|
Treatment of Advanced Sleep Phase Disorder |
290 |
|
|
Free-Running Type |
290 |
|
|
Diagnosis of Free-Running Type |
290 |
|
|
Treatment of Free-Running Type |
291 |
|
|
Irregular Sleep–Wake Rhythm |
291 |
|
|
Diagnosis of Irregular Sleep–Wake Rhythm |
291 |
|
|
Treatment of Irregular Sleep–Wake Rhythm |
292 |
|
|
Shift Work Disorder |
292 |
|
|
Diagnosis of Shift Work Disorder |
293 |
|
|
Treatment of Shift Work Disorder |
293 |
|
|
Jet Lag |
295 |
|
|
Diagnosis of Jet Lag |
295 |
|
|
Treatment of Jet Lag |
295 |
|
|
Summary |
296 |
|
|
Summary of Keypoints |
297 |
|
|
References |
297 |
|
|
Chapter 16: Narcolepsy and Idiopathic Hypersomnia |
304 |
|
|
Introduction |
304 |
|
|
Clinical Features |
305 |
|
|
Narcolepsy |
305 |
|
|
Idiopathic Hypersomnia |
307 |
|
|
Epidemiology |
308 |
|
|
Narcolepsy |
308 |
|
|
Idiopathic Hypersomnia |
308 |
|
|
Pathophysiology |
309 |
|
|
Narcolepsy |
309 |
|
|
Idiopathic Hypersomnia |
310 |
|
|
Diagnosis |
310 |
|
|
Narcolepsy |
310 |
|
|
Idiopathic Hypersomnia |
312 |
|
|
Differential Diagnosis |
313 |
|
|
Head Trauma and Excessive Sleepiness |
314 |
|
|
Treatment |
314 |
|
|
Nonpharmacologic Management |
315 |
|
|
Pharmacologic Management of Symptoms Common to Both Narcolepsy and Idiopathic Hypersomnia |
315 |
|
|
Pharmacologic Management of Symptoms Specific to Narcolepsy |
316 |
|
|
Cataplexy |
316 |
|
|
Fragmented Nocturnal Sleep |
317 |
|
|
Conclusion |
317 |
|
|
Summary of Keypoints |
317 |
|
|
References |
318 |
|
|
Chapter 17: Parasomnias |
322 |
|
|
Introduction |
322 |
|
|
NREM Parasomnias or Disorders of Arousal |
322 |
|
|
Confusional Arousal |
322 |
|
|
Definition |
322 |
|
|
Clinical Symptomatology |
323 |
|
|
Etiology |
323 |
|
|
Pathophysiology |
323 |
|
|
Epidemiology |
323 |
|
|
Diagnostic Workup |
323 |
|
|
Treatment |
324 |
|
|
Sleepwalking or Somnambulism |
324 |
|
|
Definition |
324 |
|
|
Clinical Symptomatology |
324 |
|
|
Etiology |
325 |
|
|
Pathophysiology |
325 |
|
|
Epidemiology |
326 |
|
|
Diagnostic Workup |
326 |
|
|
Treatment |
326 |
|
|
Sleep Terror or Pavor Nocturnus |
327 |
|
|
Definition |
327 |
|
|
Clinical Symptomatology |
327 |
|
|
Etiology |
328 |
|
|
Pathophysiology |
328 |
|
|
Epidemiology |
328 |
|
|
Diagnostic Workup |
328 |
|
|
Treatment |
328 |
|
|
REM Parasomnias |
329 |
|
|
REM Sleep Behavior Disorder |
329 |
|
|
Definition |
329 |
|
|
Clinical Symptomatology |
329 |
|
|
Etiology |
330 |
|
|
Pathophysiology |
330 |
|
|
Epidemiology |
330 |
|
|
Diagnostic Workup |
330 |
|
|
Treatment |
330 |
|
|
Parasomnia Overlap Syndrome/Status Dissociates |
332 |
|
|
Isolated Recurrent Sleep Paralysis |
333 |
|
|
Definition |
333 |
|
|
Clinical Symptomatology |
333 |
|
|
Etiology |
333 |
|
|
Pathophysiology |
333 |
|
|
Epidemiology |
333 |
|
|
Diagnostic Workup |
334 |
|
|
Treatment |
334 |
|
|
Nightmares |
334 |
|
|
Definition |
334 |
|
|
Clinical Symptomatology |
334 |
|
|
Etiology |
335 |
|
|
Pathophysiology |
335 |
|
|
Epidemiology |
335 |
|
|
Diagnostic Workup |
335 |
|
|
Treatment |
335 |
|
|
Other Parasomnias |
336 |
|
|
Sleep-Related Dissociative Disorder |
336 |
|
|
Treatment |
337 |
|
|
Sleep Enuresis |
337 |
|
|
Definition |
337 |
|
|
Clinical Symptomatology |
337 |
|
|
Etiology |
338 |
|
|
Pathophysiology |
338 |
|
|
Epidemiology |
338 |
|
|
Diagnostic Workup |
338 |
|
|
Treatment |
339 |
|
|
Sleep-Related Eating Disorder |
341 |
|
|
Definition |
341 |
|
|
Etiology |
341 |
|
|
Pathophysiology |
341 |
|
|
Clinical Symptomatology |
341 |
|
|
Epidemiology |
342 |
|
|
Diagnostic Workup |
342 |
|
|
Treatment |
342 |
|
|
Exploding Head Syndrome |
343 |
|
|
Treatment |
343 |
|
|
Catathrenia |
343 |
|
|
Treatment |
343 |
|
|
Sleep-Related Hallucinations |
344 |
|
|
Treatment |
344 |
|
|
Future Directions |
345 |
|
|
Conclusion |
345 |
|
|
Summary of Keypoints |
345 |
|
|
References |
346 |
|
|
Chapter 18: Movement Disorders |
356 |
|
|
Introduction |
356 |
|
|
Restless Legs Syndrome |
357 |
|
|
Demographics |
357 |
|
|
Diagnosis |
357 |
|
|
Associated Features |
358 |
|
|
Differential Diagnosis |
359 |
|
|
Primary vs. Secondary Factors |
359 |
|
|
Management |
360 |
|
|
Periodic Limb Movement Disorder |
362 |
|
|
Demographics |
362 |
|
|
Diagnosis |
362 |
|
|
Associated Features |
363 |
|
|
Differential Diagnosis |
363 |
|
|
Management |
363 |
|
|
Sleep-Related Leg Cramps |
364 |
|
|
Diagnosis |
364 |
|
|
Demographics |
364 |
|
|
Differential Diagnosis |
365 |
|
|
Associated Features |
365 |
|
|
Treatment |
365 |
|
|
Sleep-Related Bruxism |
367 |
|
|
Demographics |
367 |
|
|
Diagnosis |
367 |
|
|
Differential Diagnosis |
367 |
|
|
Associated Features |
368 |
|
|
Management |
368 |
|
|
Sleep-Related Rhythmic Movement Disorder |
369 |
|
|
Demographics |
369 |
|
|
Diagnosis |
369 |
|
|
Associated Features |
370 |
|
|
Differential Diagnosis |
370 |
|
|
Treatment |
371 |
|
|
Conclusion |
371 |
|
|
Summary of Keypoints |
371 |
|
|
References |
372 |
|
|
Chapter 19: Perioperative Care of Patients with Obstructive Sleep Apnea Syndrome |
377 |
|
|
Introduction |
377 |
|
|
Preoperative Risk Assessment and OSA Screening Protocols |
378 |
|
|
Factors Contributing to Increased Risk of Complications in Surgical Patients |
378 |
|
|
Morbid Obesity and OSA |
379 |
|
|
Preoperative Evaluation |
379 |
|
|
Preoperative Screening for Suspected OSA |
379 |
|
|
The Berlin Questionnaire |
380 |
|
|
The American Society of Anesthesiologists’ Checklist |
380 |
|
|
The STOP Questionnaire |
380 |
|
|
The STOP-Bang Model |
381 |
|
|
Sleep Apnea Clinical Score |
381 |
|
|
Preoperative Evaluation of Known OSA |
383 |
|
|
Preoperative OSA Optimization |
384 |
|
|
Intraoperative OSA Management |
384 |
|
|
Choice of Anesthetics/Anesthetic Technique |
384 |
|
|
Increased Risk of Difficulty with Tracheal Intubation |
385 |
|
|
Postoperative OSA Management |
386 |
|
|
Postoperative Pain Control |
386 |
|
|
Postoperative Monitoring |
387 |
|
|
Oximetry |
387 |
|
|
Capnography |
388 |
|
|
Management Algorithms |
388 |
|
|
PACU |
388 |
|
|
Intervention Protocols |
392 |
|
|
General Surgery |
392 |
|
|
Intervention Protocols in Orthopedic Surgery |
392 |
|
|
Intervention Protocols in Gastric Bypass Surgery Patients |
393 |
|
|
Conclusion |
394 |
|
|
Summary of Keypoints |
394 |
|
|
References |
395 |
|
|
Chapter 20: Sleep and Critical Illness |
400 |
|
|
Introduction |
400 |
|
|
Why Care? |
401 |
|
|
Measurement of Sleep During Critical Illness |
402 |
|
|
Nature and Extent of Sleep Disturbances |
403 |
|
|
Causes and Cures |
404 |
|
|
Conclusion |
407 |
|
|
Summary of Keypoints |
407 |
|
|
References |
408 |
|
|
Index |
411 |
|